LADENBURG THALM/SH SH downgraded shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE – Free Report) from a buy rating to a neutral rating in a research report sent to investors on Monday morning, FlyOnTheWall reports. Separately, StockNews.com started coverage on shares of Zynerba Pharmaceuticals in a research report on Thursday, August 10th. They set a sell rating for […]
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Zynerba Pharmaceuticals, Inc. to Harmony.
North American Morning Briefing: Stock Futures -2- morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.
Piper Sandler lowered the price target for Riskified Ltd. (NYSE: RSKD) from $8 to $7. Piper Sandler analyst Brent Bracelin maintained an Overweight rating. Riskified shares gained 12% to close at $4.77 on Tuesday.